Quick Answer
Ocugen, Inc. reported Cash And Cash Equivalents At Carrying Value of $39.46 million for the year ending 2023.
- Ocugen, Inc. showed a decrease of -26.2% in Cash And Cash Equivalents At Carrying Value from 2023 to 2023.
- This data is from Ocugen, Inc.'s annual report (Form 10-K), filed with the SEC on April 16, 2024.
- XBRL data for this metric is available from 2013 to 2023 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2013 to 2023), Ocugen, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 351.8%.
- Historical annual values: Fiscal year 2023: $39.46 million | Fiscal year 2023: $53.48 million | Fiscal year 2023: $70.58 million | Fiscal year 2023: $68.26 million | Fiscal year 2022: $77.56 million | Fiscal year 2022: $101.60 million | Fiscal year 2022: $115.01 million | Fiscal year 2022: $129.77 million | Fiscal year 2021: $94.96 million | Fiscal year 2020: $24.04 million | Fiscal year 2019: $7.44 million | Fiscal year 2018: $1.63 million | Fiscal year 2017: $7.08 million | Fiscal year 2016: $31.91 million | Fiscal year 2015: $30.92 million | Fiscal year 2014: $58.53 million | Fiscal year 2013: $8.73 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: